Gene therapy forms a major part of the cell and gene therapy market, and is expected to have the largest growth

LONDON, February 23, 2021 (GLOBE NEWSWIRE) – New Year, new updates! Our reports have been revised in relation to the market size, forecasts and strategies to be implemented in 2021 following the impact of COVID-19:

According to a research report by The Business Research Company on the cell therapy and gene therapy market, the gene therapy market represented the largest segment of the cell and gene therapy market segmented by product, making 72.4% of the total in 2020 segment of gene therapy is expected to be the fastest growing segment by product, with a CAGR of 30.8% during 2020-2025.

Therefore, the main opportunities in the gene therapy industry, segmented by-products, will appear in the gene therapy segment, which will gain $ 8.97 billion global annual sales by 2025. The biggest opportunities in the market of application-segmented cell and gene therapy will appear in oncology segment, who will receive $ 6.73 billion global annual sales by 2025. The size of the cell market and gene therapy will gain the most in USA u $ 3.36 billion.

Genes are the basic physical and functional unit of inheritance given to one’s parents. Genes act as a code for the creation of all proteins in a living organism. Gene therapy seeks to manipulate a patient’s cells to alter the biological properties of cells to treat an inherited or acquired disease. It works on several mechanisms, including replacing the disease-causing gene with a healthy copy of the gene, inactivating a defective disease-causing gene, or introducing a modified gene into the body to treat the disease. On the other hand, cell therapy seeks to treat diseases by altering certain sets of cells. In the cell therapy market, cells derived from a patient or donor are modified outside the body and then injected into the patient. This technique replaces dysfunctional cells with functional ones.

Business research company‘s report with title Global Cell and Gene Therapy Market Report 2020-30: COVID-19 Growth and Change covers major cell and gene therapy companies, cell and gene therapy market share by companies, cell and gene therapy manufacturers, cell and gene therapy market size, and cell and gene therapy market forecasts. The report also covers the global market for cell and gene therapy and its segments.

Ask for a sample of global cell and gene therapy Market report:

The global market for cell and gene therapy has reached a value of almost $ 4.39 billion 2020, increasing the compound annual growth rate (CAGR) of 25.5% from 2015. The market is expected to grow from $ 4.39 billion in 2020 $ 15.48 billion 2025 at the rate of 28.7%. Then the market growth of CAGR is expected from 17.3% from 2025. and reach $ 34.31 billion in 2030.

The global market for cell and gene therapy is highly concentrated, with a small number of large players. The ten best competitors the market consisted of almost the entire market – up to a 97.46% share total market in 2019. Major market players include Biogen Inc., Novartis AG, Gilead Sciences, Ionis Pharmaceuticals, Inc. and Alnylam Pharmaceuticals, Inc.

Global Cell and Gene Therapy Market Report 2020-30: COVID-19 Growth and Change is one in a series of new reports from Business research company providing market overviews, analyzing and forecasting market size and growth for the entire market, segments and geographic regions, trends, drivers, constraints, revenues, profiles and market shares of leading competitors in over 1,000 industry reports, covering over 2,500 market segments and 60 geographic areas . The report also provides a detailed analysis of the impact of COVID-19 on the market. The reports rely on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. An extremely experienced and professional team of analysts and modelers provides market analysis and forecasting. The reports identify leading countries and segments for opportunities and strategies based on market trends and approaches of leading competitors.

Here is a list of similar Business Research Company reports:

Global Stem Cell Therapy Market Report 2020-30: COVID 19 Growth and Change

CAR-T therapy market – according to target antigen (CD19 therapy, CD22 therapy, BCMA therapy, other), application (acute lymphoblastic leukemia, diffuse large B-cell lymphoma, follicular lymphoma, chronic lymphocytic leukemia, multiple myeloma, other), and Po regions, opportunities and strategies – a global forecast until 2030

Global Report on the Market for Gene Therapy Based on Nucleic Acid 2020

Global Gene Therapy Market Report 2021: Growth and Change COVID 19 to 2030

Global Biotechnology Services Market Report 2021: Impact and Recovery COVID 19 to 2030

Interested in more about a business research company?

A business research company is a market intelligence firm that excels in researching companies, markets and consumers. Located globally, it has special advisors in a wide range of industries, including manufacturing, healthcare, financial services, chemicals and technology.

The most comprehensive database in the world

The main product of the business research company, Global market model, is a market intelligence platform covering various macroeconomic indicators and metrics in 60 geographical areas and 27 industries. The global market model covers multi-layered datasets that help their users assess demand and demand gaps.

Contact Information

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 8897263534

Americas: +1 315 623 0293

Email: [email protected]

Follow us on LinkedIn:

Follow us on Twitter: